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Protein posttranslational modifications (PTMs) play a cen-
tral role in the DNA damage response. In particular, pro-
tein phosphorylation and ubiquitination have been shown
to be essential in the signaling cascade that coordinates
break repair with cell cycle progression. Here, we per-
formed whole-cell quantitative proteomics to identify
global changes in protein ubiquitination that are induced
by DNA double-strand breaks. In total, we quantified more
than 9,400 ubiquitin sites and found that the relative abun-
dance of 10% of these sites was altered in response to
DNA double-strand breaks. Interestingly, a large propor-
tion of ribosomal proteins, including those from the 40S as
well as the 60S subunit, were ubiquitinated in response to
DNA damage. In parallel, we discovered that DNA damage
leads to the inhibition of ribosome function. Taken to-
gether, these data uncover the ribosome as a major
target of the DNA damage response. Molecular & Cel-
lular Proteomics 17: 2297–2308, 2018. DOI: 10.1074/mcp.
RA118.000652.
The genome of a cell is frequently damaged by insults
generated by internal (reactive cell metabolites) and external
(irradiation, UV) sources (1–3). This causes a threat to the
stability of the genome and can contribute to cancer devel-
opment. To protect themselves against this potential threat,
cells are equipped with powerful surveillance mechanisms
that detect and repair the damage before it is propagated to
subsequent daughter cells. This response is collectively re-
ferred to as the DNA damage checkpoint or the DNA damage
response (1–3). Notwithstanding these harmful effects of DNA
damage, several DNA damaging agents are widely applied to
treat cancer, as they can cause a nonreversible checkpoint
arrest or trigger cell death, thus curbing the rapid proliferation
in cancer cells. For example, doxorubicin, which induces DNA
double-strand breaks, is a potent anticancer drug that is
commonly used in the clinic.
Execution of the DNA damage response requires damage
detection, and initiates a signaling cascade that halts further
progression through the cell cycle, while promoting repair.
This signaling cascade is mainly driven by posttranslational
modifications (4, 5). The phosphatidylinositol 3-kinase-related
kinases ataxia-telangiectasia mutated (ATM) and ataxia- and
Rad3- related (ATR) play a central role in the initiation of DNA
damage response signaling. ATM and ATR are recruited to
sites of DNA damage and subsequently phosphorylate over
700 substrates (6). Important downstream targets of ATM and
ATR are Chk2 and Chk1 kinases, respectively (3). Phospho-
rylation of these effector kinases results in their activation,
causing a subsequent wave of protein phosphorylations that
are essential for the function of the DNA damage checkpoint
and promotes cell cycle arrest (3, 6, 7).
A recent proteomics study showed that ubiquitination
events following DNA damage are as common as phospho-
rylation (8). It is well established that in response to a double-
strand break, ubiquitin-mediated signaling is initiated by the
ubiquitin ligases RNF8 and RNF168 (9–13). Whereas phos-
phorylation events spread rapidly throughout the nucleus af-
ter damage, ubiquitination seems mostly limited to the prox-
imity of the break site and more controlled (10, 12). Protein
ubiquitination is essential for the buildup of the checkpoint
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and plays an important role in various repair pathways. Ex-
cessive protein ubiquitination can be detrimental for the main-
tenance of the DNA damage checkpoint and DNA repair
pathway choice (14–16).
There are several reports showing that individual ribosomal
proteins play a role in the DNA damage response, most no-
tably in the activation of p53 (17, 18), but so far there are few
reports that connect the DNA damage response with ribo-
somal function. DNA damage is known to affect mRNA trans-
lation by disruption of cap initiation complexes that are re-
quired for the recruitment of mRNAs to ribosomes (19, 20). In
addition, DNA damaging agents have been shown to affect
signaling through the mTOR pathway and, in consequence,
also protein translation. In fact, the effects of irradiation on
translation are much more pronounced than on transcription
(21). These changes in translation are at least in part mediated
through altered recruitment of mRNAs to polysomes (21), but
how this is established is not known.
The eukaryotic 80S ribosome consists of four ribosomal
RNAs (rRNAs) and 80 ribosomal proteins (RPs) (22–24). After
their transcription in the nucleoli, rRNAs associate with RPS
and RPL proteins in the nucleus, forming the small (40S) and
large (60S) ribosomal subunits, respectively (22–24). The
small and large subunits will be assembled together in the
cytoplasm to make a mature ribosome (or monosome) (22–
24). Importantly, several ribosomes can simultaneously trans-
late a single mRNA molecule to synthesize the same protein,
forming the so-called polysomes (22, 23).
In this study, we investigate how specific ubiquitination
events change after DNA damage and identify the ribosome
as a target of the DNA damage checkpoint.
MATERIALS AND METHODS
Cell Culture, Transfection, and Drugs—U2OS cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 6%
fetal bovine serum and penicillin/streptomycin. Thymidine and doxo-
rubicin were purchased from (Sigma-Aldrich, St. Louis, Missouri) and
used at 2.5 mM and 1 M, respectively. ATM inhibitor KU55933 from
(Calbiochem, San Diego, CA) and ATR inhibitor VE-821 from (Axon
MedChem, Reston, VA) were used at concentration 10 M each.
MG132 was purchased from (Merck Millipore, Darmstadt, Germany)
and used at 5 M. Cycloheximide was purchased from Sigma and
used between 50 and 100 g/ml. DUB inhibitor PR-619 was from
(Tebu-bio, the Netherlands) and used in the lysis buffer at the con-
centration of 50 M. Cell synchronization and DNA damage applica-
tion were performed as previously described (25) and outlined sche-
matically in Fig. 1A and Fig. S3.
Antibodies—The antibody for diglycyl-remnant peptide enrichment
was obtained from (Cell Signaling Technology, Danvers, MA) and
used according to the standard protocol from the company. The
following antibodies were used for immunofluorescence and Western
blotting experiments: anti-nucleophosmin 1 and anti-nucleolin (Ab-
cam, Cambridge, MA, 1:1,000), anti-RPL24 (Thermo Scientific, Wal-
tham, MA, 1:1,000), anti-RPS27/27L (Thermo Scientific, 1:200), anti-
RPL26 (Bethyl Laboratories, Montgomery, TX, 1:1,000), anti- RPL27a
(Novus, 1:1,000), anti-RPS6 (Cell Signaling Technology, 1:500), anti-
pS139-H2AX (Millipore, 1:1,000), and anti--tubulin (1:5,000, Sigma).
Nascent Protein Synthesis Analysis—G2-synchronized U2OS cells
were washed with PBS and cultured in methionine-free DMEM (Invit-
rogen, Carlsbad, CA) for 30 min to deplete the intracellular methionine
reserves. Cells were then treated with a pulse of doxorubicin for 1 h
to induce double-strand breaks. After washout, cells were incubated
with the methionine analog L-azidohomoalanine (AHA; Invitrogen) for
2 h; cells were treated with the translation inhibitor cycloheximide or
with no AHA as negative controls. Cells were fixed in 3.7% formal-
dehyde, permeabilized with 0.5% Triton X-100 in PBS and blocked
using 3% bovine serum albumin in PBS. Proteins containing AHA
were labeled with Alexa Fluor488-alkyne using a click chemistry-
based reaction (Click-iT, Life Technologies). Cells were counter-
stained with DAPI to stain the nuclei. The amount of nascent protein
synthesis in each condition was quantified by measuring AHA fluo-
rescence intensity per cell using a macro developed for that purpose
in ImageJ.
Sucrose Gradients—U2OS cells were lysed in lysis buffer (20 mM
Tris-HCl, pH 7.5, 10 mM MgCl2, 100 mM KCl, 1% NP40) supple-
mented with 2 mM DTT, 100 g/ml cycloheximide, EDTA-free prote-
ase inhibitor mixture (Roche), and RiboLockRNAse inhibitor (40 U/ml,
Life Technologies). Lysates were centrifuged at 1,300 g and the
supernatant was fractionated on a linear sucrose gradient (7–47%)
using a SW-41Ti rotor at 36,000 rpm for 2 h. Thirteen fractions were
collected, and samples were analyzed by Western blotting using the
indicated antibodies.
Experimental Design and Statistical Rational Preparation of Cell
Lysates for Proteomics Analysis—U2OS cells were synchronized in G2
phase. Subsequently, 1-h doxorubicin pulse was applied. Upon re-
moval of doxorubicin, cells were incubated in fresh media containing
5 M MG132 for 2 h and 6 h and subsequently harvested for pro-
teomics analysis.
Undamaged cells with MG132 treatment are the control for this
experiment. The time scale of this experiment is presented in Fig. 1A.
To ensure the reproducibility, two independent experiments were
carried out. Each experiment contains two time points and their
respective controls.
For the ATM/ATR inhibitor experiment, G2-synchronized U2OS
cells were treated with 10 M ATM- and ATR-inhibitors for half an hour
before DNA damage induction. DNA damage was induced by a pulse
of doxorubicin. Upon removal of doxorubicin, cells were incubated in
fresh media containing 5 M MG132 for 2 h, and cells were subse-
quently harvested for proteomics analysis. Doxorubicin- and MG132-
treated cells without ATM and ATR inhibition are the control for this
experiment. Time scale is presented in Fig. S3.
For the MG132 versus DMSO experiment, U2OS cells were syn-
chronized in G2 phase and 1-h doxorubicin pulse was applied. Upon
removal of doxorubicin, cells were incubated in fresh media with and
without 5 M MG132 for 2 h and subsequently harvested for proteom-
ics analysis.
Protein Extraction, Proteolytic Digestion, and Peptide Purification—
Harvested cells were lysed using ultrasonicator for three times 1 min
at 0.6 cycle and 90% amplitude and proteins were extracted using 50
mM ammonium bicarbonate buffer containing 8 M urea, protease
inhibitors, and 50 M deubiquitinase inhibitor PR619. For each sam-
ple, 20 mg protein were reduced and alkylated using 5 mM DTT and
10 mM chloroacetamide, respectively. Subsequently, samples were
digested with lys-C (1:50 w/w enzyme:protein ratio). After buffer di-
lution (to 2 M urea), samples were digested with trypsin (1:50 w/w
enzyme:protein ratio). The peptide product was then purified using a
Seppak C8 column and concentrated using a speedvac. Finally, the
1 The abbreviations used are: FTMS, Fourier transformation
mass spectrometry; ITMS, ion trap mass spectrometry; IP,
immunoprecipitation.
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purified peptides were reconstituted in the immunoprecipitation
buffer for further enrichment by immunoprecipiation with an antibody
recognizing the diglycyl-remnant. The immunoprecipitation buffer
was supplied by Cell Signaling Technology as part of the enrichment
kit. Details on extraction, digestion, and peptide purification were
described previously (26, 27).
Peptide Enrichment and MS Analysis—Following diglycyl-remnant
peptide enrichment, peptides were eluted in two subsequent washes
using a total of 105 l of 0.15% TFA. Twenty-five microliter of sam-
ples were injected in triplicate into the nano-UPLC Proxeon system
(Easy-nLC 1000, Thermo Scientific) coupled to an Orbitrap Elite mass
spectrometer (Thermo Scientific). The injected samples were first
trapped on an in-house packed trap column (ReproSil-Pur C18-AQ, 3
m (Dr. Maisch GmbH, Ammerbuch, Germany) 2 cm  100 m)
before being separated with 2 h gradient on an in- house made
analytical column (Zorbax SB-C18, 1.8 m (Agilent Technologies,
Baltimore, MD, USA) 50 cm 50 m) at a constant temperature of 40
degrees. For the Orbitrap Elite a voltage of 1.7 kV was applied to the
needle. The survey scan was recorded with a resolution of 60,000.
The 20 most intense precursors were selected for subsequent frag-
mentation using HCD as the activation technique. Singly and doubly
charged ions were excluded in the analysis.
Ubiquitin/Peptide-site Identification and Quantification, Data Anal-
ysis, and Evaluation—Raw data were processed using MaxQuant
(version 1.4.0.3) (28) and the MS/MS data were queried against the
human UniProt database (23,630 entries, released 2013_06). Tryp-
sin/P was chosen as cleavage specificity allowing two missed cleav-
ages. Carbamidomethylation (C) was set as a fix modification, while
oxidation (M) and GlyGly (K) were used as variable modifications.
Peptide identification was based on a search with a mass deviation of
the precursor ion up to 4.5 ppm, and the allowed fragment mass
deviation was set to 20 ppm for Fourier transformation mass spec-
trometry (FTMS) and 0.5 Da for ion trap mass spectrometry (ITMS).
Data filtering was carried out using the following parameters: peptide
and protein false discovery rate were set to 1%, minimum peptide
length was set to 6, and Andromeda minimum score was set to 40
(29). MaxQuant label-free quantification was used to quantify the
ubiquitin- peptide/site, with peak area as the output. To analyze the
data, peak area of treated samples was compared with their respec-
tive controls such as with and without damage 2 h; with and without
damage 6 h; with and without ATM-/ATR- inhibitor; with and without
MG132. Log scale 2 was used to present the ratio proportionally. Data
imputation was done using the lowest peak area quantified in the
same run. Quantified sites were evaluated with Perseus (version
1.4.0.8) (30). Significant B is an outlier test provided by Perseus to
calculate the significance of a ratio based on a ratio population (from
the total data) binned by log intensity. Only ubiquitin sites that ob-
tained a p  0.01 value across replicates were considered as
changed sites. Ingenuity analysis was used to further identify com-
mon changes in the system in response to the treatment.
RESULTS
Profiling of Protein Ubiquitination in Response to DNA Dou-
ble-strand Breaks—To analyze global changes of protein
ubiquitination in response to DNA damage, G2- synchronized
U2OS cells were either left untreated or treated with a pulse of
doxorubicin to induce double-strand breaks. After doxorubicin
washout, cells were cultured in the presence of the proteasome
inhibitor MG132 to prevent the degradation of ubiquitinated
proteins, and harvested 2 h and 6 h later to profile protein
ubiquitination (Fig. 1A). Proteins were extracted, digested with
trypsin, and the ubiquitinated peptides were enriched using a
diglycyl remnant peptide antibody (31). Subsequently, peptides
were analyzed by LC-MS and quantified using MaxQuant La-
bel-Free Quantification (32) (Fig. 1B). Two independent biologi-
cal replicates were performed for each experiment.
As expected, treatment with MG132 markedly increased
the abundance of diglycine peptides compared with the
DMSO-treated control (Fig. S1A) and allowed us to detect
ubiquitinated proteins that otherwise would have been de-
graded by the proteasome in the absence of MG132. Impor-
tantly, upon treatment with doxorubicin and MG132, the over-
all levels of ubiquitin conjugates did not change (Fig. S1B),
and the types of ubiquitin linkages were not significantly al-
tered (Fig. S1C).
In total, we could identify more than 10,000 ubiquitin sites
at each time point, with an overlap of 90% of identified and
quantified sites between each biological replicate (Fig. 1C).
The overlap in sites quantified at each time point was also
high (87%, Fig. S1D). This leads to a total of more than 11,000
unique ubiquitin sites (Table S1). To validate some of the sites
identified in our large-scale analysis, we expressed a His-
tagged variant of ubiquitin in U2OS cells. After lysis, proteins
modified with His-tagged ubiquitin were pulled-down using
nickel charged beads, digested, and the ubiquitinated pep-
tides were immunoprecipitated using the ubiquitin remnant
antibody. We identified a total of 836 unique ubiquitinated
peptides, 469 of which overlapped with the peptides we
identified in our large-scale proteomics (Table S2 and Fig.
1D). Thus, close to 60% of the ubiquitin sites identified by
His-ubiquitin tagging were also identified in the direct ubiq-
uitin remnant isolation (Fig. 1D). While this provides some
validation to our large-scale ubiquitin analysis approach, it
also shows that a substantial amount of protein ubiquitina-
tion was missed in the direct ubiquitin remnant pull-downs
as compared with the His-ubiquitin pull-downs and vice
versa.
As an example of our validation, the highly ubiquitinated
NPM1 protein is shown (Fig. 1E). Our initial large-scale pro-
teomics identified six ubiquitin-sites (K32, K239, K248, K250,
K257, and K273) in NPM1. Using His-ubiquitin protein Immu-
noprecipitation (IP) as well as endogenous protein IP, we were
able to independently validate the ubiquitination on K239,
K248, K257, and K273 in NPM1. Combined, our validation
experiments indicate the robustness of our large-scale ubiq-
uitin analysis approach and thereby strengthen our findings.
Changes in Protein Ubiquitination After DNA Damage—
Using label-free quantification of diglycyl remnant peptides,
we determined changes in abundance of ubiquitinated pep-
tides between the damaged and control samples. To obtain
an overview of all of the changes in protein ubiquitination, we
subjected all of the unique sites that were identified at each
single time point to a significant B test considering both
intensity and ratio (p  0.01). This analysis provided us with a
list of 1,732 peptides from the 2 h time points (Table S3) and
2,319 peptides from the 6 h time points (Table S4) for which
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FIG. 1. Experimental setting, proteomics analysis, and validation. (A) U2OS cells were synchronized in G2 using a thymidine block,
followed by a 6-h release. Subsequently, DNA damage was induced by a 1-h doxorubicin pulse. MG132 was added after the pulse to inhibit
proteasomal degradation. Cells were harvested 2 h and 6 h after DNA damage treatment for proteomics analysis. Two biological replicates
were generated (B) proteomics platform. Following the harvest, cells were lysed and proteins were digested with trypsin. Dyglycil (di-Gly)
peptides were enriched with ubiquitin remnant peptide IP. Peptides were analyzed with LC-MS, followed by MaxQuant label-free quantifica-
tion. Three MS runs were performed and combined for each biological replicate. (C) Venn diagrams show the overlap between both biological
replicates with respect to ubiquitin sites identified in the 2-h post-damage (left) and 6-h post-damage (right) time points. (D) Independent
validation of identified ubiquitin sites. Venn diagram shows the number of ubiquitin sites identified following ubiquitin remnant peptide IP (blue)
and His-ubiquitin protein IP (red). The overlap shows the number of ubiquitin sites that were identified after both enrichment methods. (E)
Schematic representation of ubiquitin sites identified in NPM protein following di-Gly peptide IP, His-ubiquitin IP, and endogenous protein IP.
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the intensity changed at least twofold between the doxorubi-
cin-treated and the control samples. We find that 10% of all
the identified ubiquitin sites were significantly changed in
each individual run (Fig. 2A). Gratifyingly, and in line with the
important role of ubiquitination in DNA replication, recombi-
nation, and repair, we identified many proteins that were
previously shown to be regulated by ubiquitination/deubiquiti-
nation in response to DNA damage, such as Brca1, FANCD2,
FANCI, BLM, PCNA, Cdc25A, DDB2, and Histone H2A.X (Ta-
ble S1), supporting the quality of our data (33–37).
To identify the most reliable changes in protein ubiquitina-
tion that take place in response to DNA damage, we subse-
quently extracted only those peptides that passed the signif-
icant B test in both independent experiments for each single
time point. This resulted in a list of 461 sites that were repro-
ducibly regulated in both independent experiments (Tables S5
and S6). We identified 170 lysines 2 h after damage (81
decreasing and 89 increasing) and 6 h after damage this
number increased to 291 lysines (134 decreasing and 157
increasing) (Fig. 2B, Table S5 and S6). The relative overlap in
significantly regulated sites when comparing the 2 h and 6 h
time points was relatively low (5%), implying that many of the
ubiquitination events are transient and reversible. It was reas-
suring to find that the list of most reliable changes in protein
ubiquitin contained a large variety of DNA-damage-related pro-
teins (DNA- PK, Nek2, BRAT1, DDIT4, nucleophosmin, DNA
polymerase delta epsilon, HERC2, CHD4, PCNA, BRAP,
RAP80, BRCA1, BLM) (Tables S5 and S6). But more strikingly,
FIG. 2. Ubiquitome data evaluation. (A) Pie charts showing the proportion of doxorubicin-regulated ubiquitin sites over the total number of
quantified ubiquitin sites at each time point. The ubiquitin sites whose abundance increased or decreased at least twofold following doxorubicin
treatment were considered doxorubicin-regulated. (B) Scatter plots represent the correlation of the log2 ratios of doxorubicin-regulated
ubiquitin sites between the two independent experiments. Colored dots indicate sites that are significantly regulated in both experiments (p 
0.01, significant B test).
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we noticed a very high proportion of ribosomal and nucle-
olar proteins to be enriched in the list of proteins whose
ubiquitination increased upon doxorubicin treatment (Ta-
bles S5 and S6).
To confirm the overrepresentation of ribosomal proteins in
the ubiquitinated protein list, we sorted all identified ubiquitin
sites based on their ratio (Fig. 3A). Compared with the sorted
list of all ubiquitin-site changes, where ubiquitination/deubiq-
uitination is more or less equal (Fig. 3A, right panel), we
observed prominent ubiquitination of ribosomal and nucleolar
proteins after the DNA damage pulse (Fig. 3A, left panel;
Tables S5 and S6). In addition, protein deubiquitination is also
observed at a few sites in the ribosomal proteins, indicating
that ubiquitination of ribosomal proteins upon damage is not
necessarily uniformly regulated. This is further supported by
the differences we observe in the relative ratios of six ubiquitin
sites of different ribosomal proteins at both 2 h and 6 h after
the DNA damage pulse (Fig. 3B). Next, we used Ingenuity
Pathway Analysis to confirm that indeed, the ribosomal path-
way was identified as a target of protein ubiquitination after
DNA damage. The highest scoring networks identified by
Ingenuity Pathway Analysis for the 2 h and 6 h time points,
respectively, are depicted in Fig. 3C, and strikingly, both
contain a high proportion of ribosomal proteins. To confirm
that activation of the DNA damage checkpoint results in in-
creased ubiquitination of ribosomal proteins, we performed
the same ubiquitin profiling described above in the presence
of ATM and ATR inhibitors (Fig. S2A), and the changes in
protein ubiquitination were analyzed. Indeed, we found that
the ubiquitination of ribosomal and nucleolar proteins was
mostly dependent on ATM and ATR, since inhibition of these
kinases largely prevented the changes in protein ubiquitina-
tion after DNA damage (Fig. S2B). These data suggest that
activation of the DNA damage checkpoint results in a sub-
stantial, ATM/ATR-dependent change in ubiquitination of ri-
bosomal and nucleolar proteins.
We next compared our results with two recently published
large-scale ubiquitin studies (8, 38). We used the 2 h time
point from our data set because this most closely reflected
the time points used to obtain the data sets in DTT- and
ionizing-radiation-treated cells to induce endoplasmic reticu-
lum (ER)- and DNA-damage stress, respectively (Fig. S4 and
Table S7). While the overlap in the overall data sets was low,
DTT-induced ER stress also triggered widespread site-spe-
cific ubiquitination of ribosomal proteins. Further analysis
showed that a number of ribosomal proteins were ubiquiti-
nated in response to ER- as well as after DNA-damage-
induced stress (Fig. S4 and Table S7). For example, our
analysis identified five ubiquitin sites on RPS3, all of which
were also up-regulated in response to ER stress. In addition,
while no common ubiquitin sites of RPS2 and RPS20 were
found when comparing ER- and DNA-damage-induced
stress, both proteins are ubiquitinated in response to DNA
damage and ER stress. Thus, despite a very limited overall
similarity in the outcome of the different screens, ubiquitina-
tion of ribosomal proteins appears to be a common response
of cells to different forms of stress.
DNA Damage Results in a Decrease in General Protein
Translation—The function of nucleoli and ribosomes in protein
synthesis is well established (39). Since we find that a large
number of nucleolar and ribosomal proteins are ubiquitinated
following DNA damage, this sparked our interest to study the
effect of DNA damage on protein synthesis. Therefore, we
analyzed changes in global nascent protein synthesis follow-
ing DNA damage. To this end, AHA, an analog of methionine
amino acid, was added to the cell culture following a doxo-
rubicin pulse, and incorporation of AHA into newly synthe-
sized proteins was measured by Click-iT reaction (40, 41).
Significantly less AHA incorporation was observed in doxoru-
bicin-treated cells compared with DMSO-treated cells, indi-
cating a decrease in nascent protein synthesis following DNA
damage (Fig. 4A and 4B). This decrease in nascent protein
synthesis was also observed when doxorubicin was com-
bined with the proteasome inhibitor MG132 (Fig. S4A and
S4B), indicating that the effects we observe on ubiquitination
of ribosomal proteins and protein synthesis are primarily
caused by the DNA damaging insult.
Next, we aimed to test whether the decrease in global
protein synthesis was accompanied by a change in ribosome
activity. Protein synthesis involves translation of mRNA
strands by ribosomes. During active protein synthesis, several
ribosomes are attached to a single mRNA strand simultane-
ously, forming so-called polysomes. When not translationally
active, polysomes dissociate again into monosomes. Both
monosomes and polysomes can be separated on sucrose
gradients and identified by immunoblotting with antibodies
against ribosomal proteins (Fig. 4C). As a control, we inhibited
mRNA translation using an mTOR inhibitor (Torin I), which
results in a clear loss of polysomes (Fig. 4D). Similarly, a
reduction of polysomes in the doxorubicin-treated cells is
observed (Fig. 4D), indicating a decrease in ribosome activity
in response to DNA damage. Together, these results indicate
that protein translation is affected by DNA damage stress.
DNA Damage Affects the Subcellular Localization of Ribo-
somal Proteins—Depending on the type of linkage, ubiquiti-
nation can promote protein degradation or alter protein be-
havior. Particularly in the DNA damage response, protein
ubiquitination is known to play an important role in checkpoint
signaling and repair by controlling protein function. To study
the consequences of ubiquitination of ribosomal proteins, we
first studied if DNA damage induces degradation of ribosomal
proteins. We harvested cells at different time points after
doxorubicin treatment and analyzed expression levels of sev-
eral ribosomal proteins by Western blotting using commer-
cially available antibodies. Expression of nucleolin, nucleo-
phosmin, RPS6, RPL24, and RPL26 remained constant
throughout the experiment (Fig. 5A). Expression of RPS27/
27L seemed to increase during the course of the experiment,
Ubiquitination of Ribosomal Protein upon DNA Damage
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FIG. 3. Ribosomal protein ubiquitome data evaluation. (A) Plots showing the log2(damage/control) ratios of quantified ubiquitin sites on
ribosomal proteins (left panel) versus all identified proteins (right panel), at the 6 h post-damage time point, sorted according to their
ubiquitination/deubiquitination status. (B) Log2(damage/control) ratios for ubiquitinated sites on the ribosomal proteins RPL24, RPL26L1,
RPL27A, RPS6, and RPS27, both at 2 h and 6 h post-damage time points. The ubiquitinated site is indicated after the name of the protein.
(C) Interaction networks of proteins with ubiquitination sites showing a significant change 2 h (left) and 6 h (right) after the DNA damage pulse.
The highest scoring network (according to Ingenuity Pathway Analysis) for each time point is plotted. Arrows indicate an interaction, and lines
without arrowheads indicate binding. Ribosomal and nucleolar proteins are highlighted in blue and DNA damage response proteins, which are
enriched in the 6 h time point, are highlighted in orange.
Ubiquitination of Ribosomal Protein upon DNA Damage
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whereas expression of RPL27A was reduced over time (Fig.
5A). The reduction in RPL27A expression was not reverted
by addition of MG132, indicating that this reduction is not
due to enhanced proteasomal degradation (Fig. 5B). Thus,
we can conclude that, at least for the ribosomal proteins
analyzed here, DNA damage does not seem to induce in-
creased proteasomal degradation. This does not exclude
the possibility that ubiquitination can induce degradation of
some of the other ribosomal proteins that we find to be
ubiquitinated after DNA damage, but at least this shows that
DNA damage does not decrease stability of ribosomal pro-
teins in general.
Nucleolar stress produced by DNA damage has been
shown to promote the translocation of nucleolin and nucleo-
FIG. 4. DNA damage affects ribosomal function. (A) U2OS cells were synchronized in G2 as described for Fig. 1(A) and treated with
doxorubicin for 1 h in methionine-depleted media. After wash out, cells were incubated with L- azidohomoalanine (AHA) for 2 h; cells with no AHA
or treated with cycloheximide were used as negative controls. Cells were fixed and incubated with Alexa Fluor 488 alkyne to label AHA incorporation
into nascent proteins; cells were counterstained with DAPI to show the nuclei. H2AX staining is used as a marker for DNA break formation. Panels
show representative confocal images from each condition. (B) Scatter plot of individual AHA levels in no AHA, cycloheximide-, DMSO-, and
doxorubicin-treated samples from one out of the six experiments. The amount of nascent protein synthesis in each condition was quantified by
measuring AHA fluorescence intensity per cell using a macro developed for this purpose. Each bar represents mean  S.D. from each condition.
Statistical significance was determined using nonparametric Kruskal-Wallis test (***p  0.0001). (C) Lysates from DMSO-treated U2OS cells were
fractionated in sucrose density gradients to isolate the monosomes and polysomes. Thirteen fractions and the input were separated by SDS-PAGE
and immunoblotted with anti-RPL10 antibody. Fractions 6 and 11 were assigned as representative monosome- and polysome-enriched fractions.
(D) Lysates from cells treated with DMSO, doxorubicin, and Torin I were fractionated in sucrose density gradients to isolate the monosomes and
polysomes. Fractions 6 and 11 from each sample were separated by SDS-PAGE and immunoblotted with indicated antibodies.
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phosmin from the nucleolus to the nucleoplasm, and therefore
we analyzed if ubiquitination affects subcellular localization of
other ribosomal proteins in a similar manner. As expected, we
find that both nucleolin and nucleophosmin are dispersed
from the nucleolus to the nucleoplasm in response to treat-
ment with doxorubicin (Fig. 5C). In addition to nucleolin and
nucloephosmin, both RPL26 and RPS27/27L were dispersed
from the nucleoli after a pulse of doxorubicin (Fig. 5C), but
while RPS27/27L accumulated in the nucleoplasm, RPS26
was found in the the cytoplasm (Fig. 5C). No clear differences
in subcellular localization were observed for RPS6, RPL24
and RPL27A, but none of these latter ribosomal proteins
accumulated in the nucleoli in the untreated cells either (Fig.
5C). These data indicate that the enhanced ubiquitination of
ribosomal proteins that we observe after doxorubicin coincides
with nucleolar stress and disruption of the nucleoli. Based on
our data, we cannot discriminate if ubiquitination is involved in
the onset of nucleolar disruption, or if it occurs as a conse-
quence of this disruption. However, the fact that we find a clear
increase in ubiquitination of ribosomal proteins as early as 2 h
after the damaging insult could be compatible with a role in the
disruption of the nucleolus itself.
FIG. 5. Expression level and localization of nucleolar and ribosomal proteins in response to DNA damage. (A) Expression level of
ribosomal and nucleolar proteins after DNA damage. U2OS cells were synchronized in G2 and treated with a pulse of doxorubicin for 1 h. Cells
were harvested at the indicated hours post-damage (hpd), and the expression of several proteins was analyzed with the indicated antibodies.
Tubulin and ponceau S were used as loading controls. Both in (A) and (C), H2AX was used as a marker for DNA damage. (B) Same as in (A)
but with the inclusion of MG132 after the damaging insult. (C) Cellular localization of ribosomal and nucleolar proteins after DNA damage. U2OS
cells were synchronized in G2, fixed 2 h after doxorubicin pulse and stained with the indicated antibodies using immunofluorescence. Cells
were counterstained with DAPI to show the nuclei.
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DISCUSSION
In the study described here, we have profiled global
changes of protein ubiquitination in response to doxorubicin-
induced DNA damage. In a previous study, ionizing radiation
was used to induce DNA damage, and protein ubiquitination
during the early stages of DNA damage signaling was ana-
lyzed (8). In turn, our study focuses on the analysis of ubiq-
uitination not only at early time points but also at relatively late
time points after doxorubicin-induced DNA damage. The dif-
ferent experimental approaches used in each study highlights
the complementary of our work, and explains the limited
overlap between them (Fig. S3).
Similar to other studies on protein ubiquitination, we made
use of the proteasomal inhibitor MG132 to increase the
chance to retrieve ubiquitination sites before their degradation
(8). This has the potential caveat that addition of MG132 might
also lead to depletion of the free ubiquitin pool and thereby
restrict nondegradative ubiquitination. As such, it is important
to strike a balance between the inhibition of ubiquitin-depend-
ent protein degradation and the availability of free ubiquitin.
This can be achieved by applying relatively low MG132 con-
centration in a short time period, similar to the conditions
used in the present study and other previous works (34, 36,
42). Importantly, we were able to show that MG132 itself does
not grossly alter DNA-damage-induced ubiquitination (Fig.
S1). Also, the large amount of ubiquitination sites identified in
each experiment (9,000), suggests that the free ubiquitin
pool was not overly compromised. Moreover, the detection of
well-known monoubiquitinated sites in proteins such as
FANCD2 and FANCI (K561 and K523, respectively, (see Ta-
bles S3 and S4) suggests that our MG132 treatment did not
severely compromise the identification of nondegradative ubiq-
uitination sites. On the other hand, it is important to note that the
ubiquitin sites were enriched and identified based on the diglycil
remnant on the peptides following a tryptic digestion. Conse-
quently, we cannot exclude the presence of some other ubiq-
uitin-like molecules containing C-terminal diglycil motifs in the
data set (34, 43). These include neddylated proteins, whose role
in DNA damage response has previously been reported (43).
Also, without an analysis at the proteome level we cannot de-
convolute the contribution of change in protein expression on
the change in level of ubiquitination observed.
We find that at 6 h post-doxorubicin treatment, proteins
with a function in the DNA replication, recombination, and
repair are substantially ubiquitinated. Network analysis also
showed that a large group of ribosomal and nucleolar proteins
are ubiquitinated in response to DNA damage. Since the main
function of the ribosome is to synthesize proteins, we hypoth-
esized that DNA-damage-induced signaling could suppress
ongoing protein translation, as previously reported after other
types of DNA damage such as -irradiation or UV (44, 45) The
resulting inability to generate new proteins could help pre-
venting further progression through the cell cycle, allowing
more time to repair the damage (46). Indeed we find that DNA
damage results in a rapid inhibition of protein synthesis.
But how does DNA damage control protein synthesis? DNA
damage can affect initiation of protein translation through the
mTOR signaling pathway (47–49), but additional mechanisms
that control protein synthesis in response to DNA damage
might very well exist. Recently, Higgins et al. proposed site-
specific regulatory ubiquitination of 40S ribosomal proteins as
a novel mechanism to inhibit protein translation in response to
cellular stress, in particular following ionizing radiation or DTT
treatment (8, 38). Similar to those studies, we also find exten-
sive ubiquitination of ribosomal proteins following doxorubicin
treatment, several of which identical to proteins identified in
these earlier studies (RPS2, RPS3, RPS20) (Fig. S3 and Table
S7). Moreover, we have identified many additional sites on
ribosomal proteins that are ubiquitinated in response to doxo-
rubicin, and that could also affect ribosome activity. Alterna-
tively, DNA damage could affect ribosome biogenesis and in
this way inhibit protein translation in a more general fashion.
Indeed, we observe a clear nucleolar stress response after
doxorubicin treatment, as both nucleolin and nucleophosmin
disperse from the nucleolus. Translocation of nucleophosmin
during nucleolar stress was recently shown to require S-gluta-
thionylation, which occurs within minutes and can promote the
activation of p53 (50). Our measurements of protein ubiquitina-
tion were performed as early as 2 h after the damage, at a time
point when the nucleolar dispersement is well underway. Thus,
further experiments are required to resolve if the ubiquitination
plays a role in the translocation of ribosomal proteins from the
nucleolus or if it is a mere consequence of the dispersal.
It is tempting to speculate that ubiquitination of ribosomal
proteins is involved in the inhibition of protein translation that
we observe in response to doxorubicin treatment. Given the
large number of ubiquitination events, it will be challenging to
provide direct evidence for this, since each single event could
potentially contribute to it. Nonetheless, closer examination of
a selected number ubiquitination sites could prove very in-
formative. RPS6, for example, is a component of the 40S
subunit and localizes at the interface between two ribosomal
subunits. It interacts with mRNA, tRNA and initiation factors
(22, 49), indicating that it sits at an important interface during
protein translation. Therefore, an in-depth analysis of RPS6
ubiquitination, combined with their effects on protein transla-
tion is likely to generate interesting insights. In addition, ribo-
somal proteins can also be highly selective in controlling
protein translation. For example, RPL26 can specifically con-
trol p53 translation by interacting with the p53 mRNA (18). At
the same time, p53 has been reported to induce the expres-
sion of RPS27L after the treatment with the DNA damaging
agent etoposide (51), a similar increase to what we observe in
response to doxorubicin (Fig. 5A).
We find extensive ubiquitination of ribosomal proteins at 2 h
and 6 h after the induction of DNA damage. Interestingly, Elia
and co-workers reported no significant change in ubiquitina-
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tion of ribosomal proteins at earlier time points after damage
(8). Thus, it is possible that ribosomal protein ubiquitination is
part of the intermediate-to-late DNA damage response. It
would therefore be interesting to study the role of ribosomal
proteins during recovery from a DNA-damage-induced arrest.
In this respect, it is interesting to note that we find that
depletion of several ribosomal proteins results in a substantial
decrease in recovery from a G2 arrest (data not shown).
Similarly, depletion of RPS27L resulted in a deficiency in DNA
damage checkpoints, leading to a shift of DNA-damage-in-
duced p53 response from cell cycle arrest to apoptosis (52).
How ribosomal proteins or their ubiquitination affects recov-
ery is not clear. Recently, an E3 ligase complex with a role in
nonfunctional rRNA decay has been identified and its associ-
ated protein Mms1p, identified previously as factor involved in
DNA repair (53). Several studies have linked ribosomal pro-
teins to the activation of p53, controlling its abundance either
by binding to p53 mRNA or by binding to its ubiquitin ligase
MDM2 (17, 54–56). Given the crucial role for p53 in the control
of cell cycle re-entry in G2 (57, 58) these extra-ribosomal
functions could prove important.
In summary, our proteomics study provides a useful data
set of protein ubiquitination events that occur in response to
DNA damage. Our set further expands previously published
data sets and provides the first global analysis of protein
ubiquitination at early and late time points after treatment with
doxorubicin. In addition, our study highlights the extensive ef-
fects of DNA damage on ubiquitination of ribosomal proteins, as
well as its effects on protein synthesis. While we would like to
unravel the molecular details that could link these events, the
large number of ubiquitination events that we and others find
represents a huge challenge. Nonetheless, the fact that many
subunits of the ribosome are affected during a stress response
strongly implies that tight control of ribosomal function is
crucial for the cellular response to stress.
Acknowledgments—This work is funded by a TOP-GO grant from
the Netherlands Organization for Scientific Research (NWO ZonMW
912100651 to R.H.M., S.M., and V.A.H.). I.G.S. was supported with a
postdoctoral fellowship from the Basque Country Government
(Spain). We thank Christian Frese and Teck Yew Low for fruitful
discussions. We also thank Teck Yew Low for submitting the raw files
and annotated spectra to PRIDE. We thank Fabricio Loayza-Puch for
his technical help with the sucrose gradients.
DATA AVAILABILITY
All raw files and annotated spectra from these experiments
are available on PRIDE (https://www.ebi.ac.uk/pride/archive;
Project ID PXD004445).
□S This article contains supplemental material Tables S1 to S7 and
Figs. S1-S4.
To whom correspondence should be addressed: E-mail:
r.medema@nki.nl.
¶¶ Shared first author.
Author contributions: V.A.H., I.G.-S., D.O.W., S.M., and R.H.M.
designed the research; V.A.H. and I.G.-S. performed research; V.A.H.,
I.G.-S., and R.H.M. analyzed data; V.A.H., I.G.-S., S.M., and R.H.M.
wrote the paper; B.v.d.B. contributed new reagents/analytic tools;
A.J.R.H. supervision; S.M. and R.H.M. supervision.
REFERENCES
1. Bartek, J., and Lukas, J. (2007) DNA damage checkpoints: From initiation
to recovery or adaptation. Curr. Opin. Cell Biol. 19, 238–245
2. Jackson, S. P., and Bartek, J. (2009) The DNA-damage response in human
biology and disease. Nature 461, 1071–1078
3. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kac¸maz, K., and Linn, S. (2004)
Molecular mechanisms of mammalian DNA repair and the DNA damage
checkpoints. Annu. Rev. Biochem. 73, 39–85
4. Ciccia, A., and Elledge, S. J. (2010) The DNA damage response: Making it
safe to play with knives. Mol. Cell. 40, 179–204
5. Harper, J. W., and Elledge, S. J. (2007) The DNA damage response: Ten
years after. Mol. Cell 28, 739–745
6. Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., III, Hurov,
K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, S., Lerenthal, Y.,
Shiloh, Y., Gygi, S. P., and Elledge, S. J. (2007) ATM and ATR substrate
analysis reveals extensive protein networks responsive to DNA damage.
Science 316, 1160–1166
7. van Vugt, M. A., Smits, V. A., Klompmaker, R., and Medema, R. H. (2001)
Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or
ATR-dependent fashion. Biol. J. Chem. 276, 41656–41660
8. Elia, A. E., Boardman, A. P., Wang, D. C., Huttlin, E. L., Everley, R. A.,
Dephoure, N., Zhou, C., Koren, I., Gygi, S. P., and Elledge, S. J. (2015)
Quantitative proteomic atlas of ubiquitination and acetylation in the
damage response DNA. Mol. Cell 59, 867–881
9. Bekker-Jensen, S., and Mailand, N. (2011) The ubiquitin- and SUMO-de-
pendent signaling response to DNA double-strand breaks. Lett. FEBS
585, 2914–2919
10. Doil, C., Mailand, N., Bekker-Jensen, S., Menard, P., Larsen, D. H., Pepperkok,
R., Ellenberg, J., Panier, S., Durocher, D., Bartek, J., Lukas, J., and Lukas, C.
(2009) RNF168 binds and amplifies ubiquitin conjugates on damaged chro-
mosomes to allow accumulation of repair proteins. Cell 136, 435–446
11. Jackson, S. P., and Durocher, D. (2013) Regulation of DNA damage re-
sponses by ubiquitin and SUMO. Mol. Cell 49, 795–807
12. Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J.,
Lukas, C., and Lukas, J. (2007) RNF8 ubiquitylates histones at DNA
double-strand breaks and promotes assembly of repair proteins. Cell
131, 887–900
13. Messick, T. E., and Greenberg, R. A. (2009) The ubiquitin landscape at DNA
double-strand breaks. Cell Biol. J. 187, 319–326
14. Mailand, N., Bekker-Jensen, S., Bartek, J., and Lukas, J. (2006) Destruction
of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates
recovery from genotoxic stress. Mol. Cell 23, 307–318
15. Mamely, I., van Vugt, M. A. T. M., Smits, V. A. J., Semple, J. I., Lemmens,
B., Perrakis, A., Medema, R. H., and Freire, R. (2006) Polo-like kinase-1
controls proteasome-dependent degradation of Claspin during check-
point recovery. Curr. Biol. 16, 1950–1955
16. Peschiaroli, A., Dorrello, N. V., Guardavaccaro, D., Venere, M., Halazonetis,
T., Herman, N. E., and Pagano, M. (2006) SCFbetaTrCP-mediated deg-
radation of Claspin regulates recovery from the DNA replication check-
point response. Mol. Cell 23, 319–329
17. Lohrum, M. A., Ludwig, R. L., Kubbutat, M. H., Hanlon, M., and Vousden,
K. H. (2003) Regulation of HDM2 activity by the ribosomal protein L11.
Cancer Cell 3, 577–587
18. Takagi, M., Absalon, M. J., McLure, K. G., and Kastan, M. B. (2005)
Regulation of p53 translation and induction after DNA damage by ribo-
somal protein L26 and nucleolin. Cell 123, 49–63
19. Kumar, V., Sabatini, D., Pandey, P., Gingras, A.-C., Majumder, P. K.,
Kumar, M., Yuan, Z.-M., Carmichael, G., Weichselbaum, R., Sonenberg,
N., Kufe, D., and Kharbanda, S. (2000) Regulation of the rapamycin and
FKBP-target 1/mammalian target of rapamycin and cap-dependent ini-
tiation of translation by the c-Abl protein-tyrosine kinase. Biol. J. Chem.
275, 10779–10787
20. Paglin, S., Lee, N.-Y., Nakar, C., Fitzgerald, M., Plotkin, J., Deuel, B.,
Hackett, N., McMahill, M., Sphicas, E., Lampen, N., and Yahalom, J.
(2005) Rapamycin-sensitive pathway regulates mitochondrial membrane
potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res.
65, 11061–11070
Ubiquitination of Ribosomal Protein upon DNA Damage
Molecular & Cellular Proteomics 17.12 2307
 by guest on January 15, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
21. Lu¨, X., de la Pen˜a, L., Barker, C., Camphausen, K., and Tofilon, P. J. (2006)
Radiation-induced changes in gene expression involve recruitment of
existing messenger RNAs to and away from polysomes. Cancer Res. 66,
1052–1061
22. Nygård, O., and Nilsson, L. (1990) Translational dynamics, interactions
between the translational factors, tRNA and ribosomes during eukaryotic
protein synthesis. Eur. J. Biochem. 191, 1–17
23. de Las Heras-Rubio, A., Perucho, L., Paciucci, R., Vilardell, J., and LLeon-
art, M. E. (2014) Ribosomal proteins as novel players in tumorigenesis.
Cancer Metastasis Rev. 33, 115–141
24. Robledo, S., Idol, R. A., Cimmins, D. L., Ladenson, J. H., Mason, P. J., and
Bessler, M. (2008) The role of human ribosomal proteins in the matura-
tion of rRNA and ribosome production. RNA 14, 1918–1929
25. Macu˚rek, L. Lindqvist, A., Lim, D., Lampson, M. A., Klompmaker, R., Freire,
R., Clouin, C., Taylor, S. S., Yaffe, M. B., and Medema, R. H. (2008)
Polo-like kinase-1 is activated by aurora A to promote checkpoint re-
covery. Nature 455, 119–123
26. Boersema, P. J., Raijmakers, R., Lemeer, S., Mohammed, S., and Heck,
A. J. (2009) Multiplex peptide stable isotope dimethyl labeling for quan-
titative proteomics. Nat. Protoc. 4, 484–494
27. Gauci, S., Helbig, A. O., Slijper, M., Krijgsveld, J., Heck, A. J. R., and
Mohammed, S. (2009) Lys-N and trypsin cover complementary parts of
the phosphoproteome in a refined SCX-based approach. Anal. Chem.
81, 4493–4501
28. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification
rates, individualized p.p.b.- range mass accuracies and proteome-wide
protein quantification. Nat. Biotechnol. 26, 1367–1372
29. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and
Mann, M. (2011) Andromeda: A peptide search engine integrated into the
MaxQuant environment. J. Proteome Res. 10, 1794–1805
30. Cox, J., and Mann, M. (2012) 1D and 2D annotation enrichment: A statis-
tical method integrating quantitative proteomics with complementary
high-throughput data. BMC Bioinformatics 16, S12
31. Xu, G., Paige, J. S., Jaffrey, and S. R. (2010) Global analysis of lysine
ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Bio-
technol. 28, 868–873
32. Cox, J., Heim, M. Y., Luber, C. A., Paron, I., Nagaraj, N., and Mann, M.
(2014) Accurate proteome-wide label-free quantification by delayed nor-
malization and maximal peptide ratio extraction, termed MaxLFQ. Mol.
Cell. Proteomics 13, 2513–2526
33. Tikoo, S., Madhavan, V., Hussain, M., Miller, E. S., Arora, P., Zlatanou, A.,
Modi, P., Townsend, K., Stewart, G. S., and Sengupta, S. (2013) Ubiq-
uitin-dependent recruitment of the Bloom syndrome helicase upon rep-
lication stress is required to suppress homologous recombination.
EMBO J. 32, 1778–1792
34. Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Possemato, A., Sowa, M. E.,
Rad, R., Rush, J., Comb, M. J., Harper, J. W., and Gygi, S. P. (2011)
Systematic and quantitative assessment of the ubiquitin-modified pro-
teome. Mol. Cell. 44, 325–340
35. Povlsen, L. K., Beli, P., Wagner, S. A., Poulsen, S. L., Sylvestersen, K. B.,
Poulsen, J. W., Nielsen, M. L., Bekker-Jensen, S., Mailand, N., and
Choudhary, C. (2012) Systems-wide analysis of ubiquitylation dynamics
reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat.
Cell Biol. 14, 1089–1098
36. Wagner, S. A., Beli, P., Weinert, B. T., Nielsen, M. L., Cox, J., Mann, M., and
Choudhary, C. (2011) A proteome-wide, quantitative survey of in vivo
ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Pro-
teomics 10, M111.013284
37. Mertins, P., Qiao, J. W., Patel, J., Udeshi, N. D., Clauser, K. R., Mani, D. R.,
Burgess, M. W., Gillette, M. A., Jaffe, J. D., and Carr, S. A. (2013)
Integrated proteomic analysis of post-translational modifications by se-
rial enrichment. Nat. Methods 10, 634–637
38. Higgins, R., Gendron, J. M., Rising, L., Mak, R., Webb, K., Kaiser, S. E.,
Zuzow, N., Riviere, P., Yang, B., Fenech, E., Tang, X., Lindsay, S. A.,
Christianson, J. C., Hampton, R. Y., Wasserman, S. A., and Bennett,
E. J. (2015) The unfolded protein response triggers site-specific
regulatory ubiquitylation of 40 ribosomal proteins. Mol. Cell. 59,
35–49
39. Steitz, T. A. (2008) A structural understanding of the dynamic ribosome
machine. Nat Rev. Mol. Cell Biol. 9, 242–253
40. Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A., and Schuman,
E. M. (2006) Selective identification of newly synthesized proteins in
mammalian cells using bioorthogonal noncanonical amino acid tag-
ging (BONCAT). Proc. Natl. Acad. Sci. USA 103, 9482–9487
41. Dieterich, D. C., Lee, J. J., Link, A. J., Graumann, J., Tirrell, D. A., and
Schuman, E. M. (2007) Labeling detection and identification of newly
synthesized proteomes with bioorthogonal non-canonical amino-acid
tagging. Nat. Protoc. 2, 532–540
42. Udeshi, N. D., Mani, D. R., Eisenhaure, T., Mertins, P., Jaffe, J. D., Clauser,
K. R., Hacohen, N., and Carr, S. A. (2012) Methods for quantification of
in vivo changes in protein ubiquitination following proteasome and deu-
biquitinase inhibition. Mol. Cell. Proteomics 11, 148–159
43. Brown, J. S., Lukashchuk, N., Sczaniecka-Clift, M., Britton, S., le Sage, C.,
Calsou, P., Beli, P., Galanty, Y., and Jackson, S. P. (2015) Neddylation
promotes ubiquitylation and release of Ku from DNA-damage sites. Cell
Rep. 11, 704–714
44. Guerra-Rebollo, M., Mateo, F., Franke, K., Huen, M. S. Y., Lopitz-Otsoa, F.,
Rodriguez, M. S., Plans, V., and Thomson, T. M. (2012) Nucleolar exit of
RNF8 and BRCA1 in response to DNA damage. Exp. Cell Res. 318,
2365–2376.
45. Powley, I. R., Kondrashov, A., Young, L. A., Dobbyn, H. C., Hill, K., Cannell,
I. G., Stoneley, M., Kong, Y.-W., Cotes, J. A., Smith, G. C., Wek, R.,
Hayes, C., Gant, T. W., Spriggs, K. A., Bushell, M., and Willis, A. E. (2009)
Translational reprogramming following UVB irradiation is mediated by
PKcs DNA-, allows selective recruitment to the polysomes of mRNAs
encoding DNA repair enzymes. Genes Dev. 23, 1207–1220
46. Mazumder, A., Pesudo, L. Q., McRee, S., Bathe, M., and Samson, L. D.
(2013) Genome-wide single-cell-level screen for protein abundance and
localization changes in response to DNA damage in S. cerevisiae. Nu-
cleic Acids Res. 41, 9310–9324.
47. Braunstein, S., Badura, M. L., Xi, Q., Formenti, S. C., and Schneider, R. J.
(2009) Regulation of protein synthesis by ionizing radiation. Mol. Cell.
Biol. 29, 5645–5656
48. Tee, A. R., and Proud, C. G. (2000) DNA-damaging agents cause inactiva-
tion of translational regulators linked to mTOR signalling. Oncogene 19,
3021–3031
49. Ruvinsky, I., and Meyuhas, O. (2006) Ribosomal protein S6 phosphoryla-
tion: From protein synthesis to cell size. Trends Biochem. Sci. 31,
342–348
50. Yang, K., Wang, M., Zhao, Y., Sun, X., Yang, Y., Li, X., Zhou, A., Chu, H.,
Zhou, H., Xu, J., Wu, M., Yang, J., and Yi, J. (2016) A redox mechanism
underlying nucleolar stress sensing by nucleophosmin. Nat. Commun. 7,
13599
51. He, H., and Sun, Y. (2007) Ribosomal protein S27L is a direct p53 target
that regulates apoptosis. Oncogene 26, 2707–2716
52. Li, J., Tan, J., Zhuang, L., Banerjee, B., Yang, X., Chau, J. F. L., Hand, M. P.,
Li, B., and Yu, Q. (2007) Ribosomal protein S27-like, a p53-inducible
modulator of cell fate in response to genotoxic stress. Cancer Res. 67,
11317–11326
53. Fujii, K., Kitabatake, M., Sakata, T., Miyata, A., and Ohno, M. (2009) A role
for ubiquitin in the clearance of nonfunctional rRNAs. Genes Dev. 23,
963–974
54. Dai, M.-S., Zeng, S. X., Jin, Y., Sun, X.-X., David, L., and Lu, H. (2004)
Ribosomal protein L23 activates p53 by inhibiting MDM2 function in
response to ribosomal perturbation but not to translation inhibition. Mol.
Cell. Biol. 24, 7654–7668
55. Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D.,
and Laiho, M. (2004) Nucleolar protein NPM interacts with HDM2 and
protects tumor suppressor protein p53 from HDM2-mediated degrada-
tion. Cancer Cell 5, 465–475
56. Warner, J. R., and McIntosh, K. B. (2009) How common are extraribosomal
functions of ribosomal proteins? Mol. Cell 34, 3–11
57. Krenning, L., Feringa, F. M., Shaltiel, I. A., van den Berg, J., and Medema,
R. H. (2014) Transient activation of p53 in G2 phase is sufficient to induce
senescence. Mol. Cell 55, 59–72
58. Lindqvist, A., de Bruijn, M., Macurek, L., Bra´s, A., Mensinga, A., Bruinsma,
W., Voets, O., Kranenburg, O., and Medema, R. H. (2009) Wip1 confers
G2 checkpoint recovery competence by counteracting p53- dependent
transcriptional repression. EMBO J. 28, 3196–3206
Ubiquitination of Ribosomal Protein upon DNA Damage
2308 Molecular & Cellular Proteomics 17.12
 by guest on January 15, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
